## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.4% in lower entry zone (4.0-10.0%), top quartile (88th pct) cross-sectional ranking. Caution: MRS_5 (-0.9%) diverging from MRS_20, watch for reversal. Outperforming sector by 5.4%. Caution: momentum weakening (-6.0% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($151.99)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 4
- **Sentiment:** Bearish (Bullish: 0, Bearish: 2)

**1. Molina Healthcare, Inc. (MOH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation**
- Source: ACCESS Newswire | 20251218T210831 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (NYSE:MOH) for alleged corporate wrongdoing. Shareholders who purchased Molina securities before February 5, 2025, and still hold them, are encouraged to contact the firm to assist in the investigation. The firm operates on a contingency fee basis, meaning there is no cost to the investors unless they are successful.

**2. Molina Healthcare, Inc. (MOH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation**
- Source: KGET.com | 20251218T160825 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (NYSE:MOH) for alleged corporate wrongdoing. The firm is encouraging shareholders who purchased Molina securities before February 5, 2025, and still hold them, to contact them to assist in the investigation. The representation of investors in such class actions is done on a contingency fee basis.

**3. BrightSpring Health Services (BTSG) Stock Is Up, What You Need To Know**
- Source: Finviz | 20251218T190941 | Somewhat-Bullish | Relevance: 64%
- BrightSpring Health Services (NASDAQ:BTSG) saw its stock jump 3.7% after Mizuho raised its price target to $42 and Keybanc upgraded the stock to "Overweight." These analyst actions indicate growing confidence in the company's future. The stock has been volatile but is up 111% year-to-date, reaching a new 52-week high after previously benefiting from discussions around extending Affordable Care Act subsidies.

**4. Citigroup Cuts RPM International (NYSE:RPM) Price Target to $127.00**
- Source: MarketBeat | 20251218T200924 | Neutral | Relevance: 54%
- Citigroup has reduced its price target for RPM International (NYSE:RPM) to $127.00 from $136.00, while maintaining a "buy" rating, indicating an 18.9% potential upside. Other analyst firms like Mizuho, Bank of America, Evercore ISI, and Royal Bank of Canada have also adjusted their price targets and ratings recently, contributing to a consensus "Moderate Buy" with an average target of $128.64. RPM International reported Q1 earnings that slightly beat estimates and saw a 7.4% year-over-year revenue increase, despite its shares trading down and below key moving averages.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Valuation risk: PEG 2.6x with declining EPS estimates leaves no margin for error.
2. Elevated short interest (11.4%): bears positioning against stock.
3. Long-term trend broken: trading 28.9% below SMA200.
4. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.62 signals overvaluation risk, limited margin of safety. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.9B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.62 |
| Forward P/E | 10.8 |
| Current P/E | 11.8 |
| YoY Growth | 9.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 11.4% to 5.4% (-6.0% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 (-0.9%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.7% shows strong absolute momentum above own 20MA. Outperforming sector by 5.4pp, stock-specific strength. Below SMA200 (0.71x), long-term trend not supportive. MACD histogram positive (1.72), confirming momentum. RSI neutral at 59. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.37% (CS: 89) | Strong |
| RSI_14 | 59.2 | Neutral |
| MACD Histogram | 1.72 | Bullish |
| vs SMA20 | 1.057x | Above |
| vs SMA50 | 1.029x | Above |
| vs SMA200 | 0.711x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $163.69
- **Stop Loss:** $151.99 (7.1% risk)
- **Target:** $181.24 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 102
- **Position Value:** $16,696.38
- **Portfolio %:** 16.70%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*